ABAnnelies VAN Beeck

Annelies VAN Beeck

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Annelies VAN Beeck has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Bilal Kapanci

    Chirurgie Orthopédique – Traumatologie, Clinique des Tumeurs Conjonctives et Osseuses, Institut Jules Bordet, Brussels, Belgium

    1 shared publication
  • David Putzer

    Department of Orthopaedics and Traumatology, Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria

    1 shared publication
  • Dietmar Dammerer

    Medical University of Innsbruck, Innsbruck, Austria

    1 shared publication
  • Dietmar Dammerer

    Department for Orthopaedics and Traumatology, University Hospital Krems, 3500 Krems, Austria

    1 shared publication
  • F. Verstreken

    Orthopedic department, Monica hospital, 68, Harmoniestraat, 2018 Antwerp, Belgium

    1 shared publication
  • Felix Shumelinsky

    Chirurgie Orthopédique – Traumatologie, Clinique des Tumeurs Conjonctives et Osseuses, Institut Jules Bordet, Brussels, Belgium

    1 shared publication

Latest Publications

  • Open Access

    Outcome and EBRA migration analysis of a reconstruction cage in acetabular revision arthroplasty: a clinical and radiological study

    by Dietmar Dammerer, Philipp Blum, David Putzer, Annelies van Beeck, Michael Nogler, Martin Thaler

    Purpose: Restoration cages and bone allografts have been proposed to manage severe acetabular bone defects. We aimed to investigate the migration behaviour of a restoration cup and impacted allograft bone in severe acetabular defects with Einzel-Bild-Röntgen-Analyse (EBRA). Methods: Applying a retrospective study design, 64 cases treated between 2009 and 2016 were reviewed. We determined the preoperative Charlson Comorbidity Index (CCI), pre- to postoperative WOMAC score, blood loss and functional outcome. From preoperative x rays, the acetabular deficiencies were classified according to Paprosky. Cup migration analyses were performed with EBRA. Results: Mean age at surgery was 73 (range: 38–93) years. According to the classification by Paprosky et al., 50% (n = 32) of our patients showed a type III B and 28.1% (n = 18) a type III A defect. Radiological follow-up for migration analysis was 35 (range: 4–95) months. Migration analysis showed a mean cup migration of 0.7 mm (range: 5.7–9.6) medial and 1.8 mm (range: 1.7–12.6) cranial. Conclusion: In conclusion, acetabular restoration cages in combination with bone impaction grafting showed a low revision rate at a mean follow-up of 35 months. Mean cup migration revealed low rates after 2 years and suggested a stable postoperative implant position.


  • Clinical Outcome of Surgically Treated Leiomyosarcoma of the Extremities: A Retrospective Overview

    by Annelies VAN Beeck, Michiel VAN DE Sande, Veroniek VAN Praag, Dietmar Dammerer, Jozef Michielsen, Thomas Schubert, Bilal Kapanci, Felix Shumelinsky, Johan Somville, Sander Dijkstra

    Aim: This study was interested in extremity leiomyosarcoma with focus on clinical outcome after surgery with or without adjuvant therapy. Patients and Methods: A retrospective case series of all patients with leiomyosarcoma, surgically treated between 2000 and 2015 and a minimum follow-up of 2 years, was drawn from institutional databases in Belgium and the Netherlands. Postoperative complications were reported with the Radiation Therapy Oncology Group (RTOG) and the Henderson classification. Results: Seventy-five patients were operated on, of whom 47 underwent (neo)adjuvant therapy. Infection was observed in 11 patients, seven associated with (neo)adjuvant radiotherapy. Dermatological complaints were observed in 26 patients, 10 associated with (neo)adjuvant radiotherapy. Overall survival was 60%. Local recurrence occurred in 11 (15%) patients. Conclusion: This study describes favourable clinical outcome following (neo)adjuvant radiotherapy. In the future, larger databases on leiomyosarcoma should enhance the power of these findings and define the benefits of adjuvant therapy in leiomyosarcoma.


  • Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results

    by A. Van Beeck, M. Van Den Broek, M. Michielsen, K. Didden, K. Vuylsteke, F. Verstreken